MedTrace Logo

Physical Function of Older Citizens During Municipality-based Rehabilitation

NCT04862481 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 115

Last updated 2022-03-23

No results posted yet for this study

Summary

When choosing outcomes to assess rehabilitation's effect or progress, it is essential to consider the constructs being measured and their value to the patient and the psychometric properties. Choosing an outcome that reflects all aspects of International Classification levels of Functioning, Disability and Health (ICF) is challenging, especially in heterogeneous groups. However, it is important to know the psychometric properties as this gives important knowledge on how to interpret results and, consequently, how this can inform the patient's care. The Short Musculoskeletal Function Assessment (SMFA) questionnaire can reflect differences in patients' functional status with a broad range of disorders, like for elderly citizens undergoing municipality-based rehabilitation. Nevertheless, since there is no golden standard to measure rehabilitation outcomes, construct validity needs to be established to investigate how scores of SMFA can be related to measures on all levels of ICF.

Therefore, this study has three main objectives:

1. To investigate how scores of the SMFA questionnaire are related to measures on different ICF levels
2. To describe the characteristics of older citizens starting municipality-based rehabilitation on all ICF levels
3. To investigate predictor variables of upper- and lower extremity strength

Conditions

Sponsors & Collaborators

  • University of Southern Denmark

    collaborator OTHER

  • Sundhed og Træning, Slagelse Municipality

    collaborator UNKNOWN

  • Danish Council for Independent Research

    collaborator OTHER

  • University College Absalon

    lead OTHER

Principal Investigators

  • Sanel Teljigovic, PhD student · University College Absalon & University of Southern Denmark

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-25
Primary Completion
2021-09-10
Completion
2021-09-12

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04862481 on ClinicalTrials.gov